Fatal case of haemorrhagic fever with renal syndrome
A. F. Popov,
V. A. Ivanis,
V. I. Verkhoturova,
E. V. Safronova,
T. A. Kabantsevа,
S. I. Yehlakov,
V. А. Pavlov https://doi.org/10.34215/1609-1175-2024-1-72-74
Abstract
The Far Eastern Federal District comprises an epidemic focus of hemorrhagic fever with renal syndrome (HFRS), where the incidence is determined by two orthohantaviruses: Hantaan (including its variant Amur) and Seoul. In Primorsky Krai, the average long-term incidence rate for 13 years (2011–2023) accounted for 2.7% (in some years up to 4.4% per 100 thousand population), and the mortality rate comprised 3.2% (9.1% in 2018). The distribution of clinical forms of the disease over the past 13 years revealed the prevalence of its moderate forms (66%), severe forms accounted for about 30% of all cases. The study presents a clinical case of severe course of HFRS with lethal outcome in a young male with no concomitant pathology.
About the Authors
A. F. Popov
Pacific State Medical University ; Far Eastern Federal University ; Far Eastern Branch of the State Research and Testing Institute of Military Medicine
Russian Federation
Russian Federation
Alexander F. Popov, Dr. Sci. (Med.), Professor of the Department of Epidemiology and Military Epidemiology
2 Ostryakova Ave, Vladivostok, 690002 phone: +7 (914) 704-56-20
V. A. Ivanis
Pacific State Medical University
Russian Federation
Russian Federation
Vladivostok
V. I. Verkhoturova
Regional Clinical Infectious Diseases Hospital
Russian Federation
Russian Federation
Vladivostok
E. V. Safronova
Regional Clinical Infectious Diseases Hospital
Russian Federation
Russian Federation
Vladivostok
T. A. Kabantsevа
The Vladivostok Clinical Hospital № 2
Russian Federation
Russian Federation
Vladivostok
S. I. Yehlakov
The Vladivostok Clinical Hospital № 2
Russian Federation
Russian Federation
Vladivostok
V. А. Pavlov
The Vladivostok Clinical Hospital № 2
Russian Federation
Russian Federation
Vladivostok
References
1. Tkachenko EA, Ishmukhametov АА, Dzagurova ТК, Bernshtein АD, Morozov VG, Siniugina AA, Kurashova SS, Balkina AS, Tkachenko PE, Kruger DH, Klempa B. Hemorrhagic Fever with Renal Syndrome, Russia. Emerg Infect Dis. 2019;25(12):2325–8. doi: 10.3201/eid2512.181649
2. Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, Kochanek M, Böll B, BergweltBaildonet MS. Cytokine release syndrome. J. Immunother. Cancer. 2018;6:559–70. doi: 10.1186/s40425-018-0343-9
3. Tanaka T, Narazaki M, Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy. 2016;8(8):959–70. doi: 10.2217/imt-2016-0020
4. Shakirova VG, Martynova EV, Saubanova AR. Analysis of markers of renal damage in patients with hemorrhagic fever with renal syndrome. Practical Medicine. 2019;17(8):97–102 (In Russ.). doi: 10.32000/2072-1757-2019-8-97-102
5. Popov AF, Ivanis VA, Verkhoturova VI, Iunikhina OV. A fatal case of hemorrhagic fever with renal syndrome. Far Eastern Medical Journal. 2023;1:83–6 (In Russ.) doi:10.35177/1994-5191-2023-1-14.
6. Popov AF, Ivanis VA, Pereverten LYu, Sklyar LF. Severe case of hemorrhagic fever with renal syndrome. Pacific Medical Journal. 2022;2:98–100 (In Russ.). doi: 10.34215/1609-1175-2022-2-94-96
Review
For citations:
Popov A.F., Ivanis V.A., Verkhoturova V.I., Safronova E.V., Kabantsevа T.A., Yehlakov S.I., Pavlov V.А. Fatal case of haemorrhagic fever with renal syndrome. Pacific Medical Journal. 2024;(1):72-74. (In Russ.) https://doi.org/10.34215/1609-1175-2024-1-72-74
Views:
493
Email this article 